David J Klinke

12PUBLICATIONS
2CO-AUTHORS
Cancer cell biologyPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jan 16, 2026
Cell Communication Network factor 4 promotes tumor-induced immunosuppression in breast cancer.

David J Klinke, Atefeh Razazan, Anika C Pirkey

|Aug 29, 2025
A functional comparison of two transplantable syngeneic mouse models of melanoma: B16F0 and YUMM1.7.

David J Klinke, Alanna Gould, Anika Pirkey

|Jul 15, 2025
A functional comparison of two transplantable syngeneic mouse models of melanoma: B16F0 and YUMM1.7.

David J Klinke, Alanna Gould, Anika Pirkey

|Dec 15, 2023
Head-to-Head Comparison of CCN4, DNMT3A, PTPN11, and SPARC as Suppressors of Anti-tumor Immunity.

Anika C Pirkey, Wentao Deng, Danielle Norman

|Apr 14, 2022
Data-driven learning how oncogenic gene expression locally alters heterocellular networks.

David J Klinke, Audry Fernandez, Wentao Deng

|Jan 31, 2022
Cell Communication Network factor 4 promotes tumor-induced immunosuppression in melanoma.

Audry Fernandez, Wentao Deng, Sarah L McLaughlin

Pageof 2

Frequent Collaborators

2 joint publications

Anika C Pirkey

1 joint publications

Habibolla Latifizadeh